Indomethacin and the Nephrotic Syndrome

Isam H. Shehadeh, Anton C. Schoolwerth, Arthur B. Abt, Laurence Demers

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Treatment of membranous nephropathy and the nephrotic syndrome with 2 mg/kg/day of indomethacin resulted in prompt and sustained reduction in urinary protein excretion and the loss of edema fluid, which allowed the withdrawal of diuretic therapy and liberalization of salt intake. The reduction in proteinuria was paralleled by a decrease in urinary prostaglandin E (PGE) and F (PGF) levels. Plasma PGE and PGF levels did not change appreciably. Withdrawal of indomethacin therapy resulted in an increase in urinary protein and urinary PGE excretion. Reinstitution of therapy resulted in reductions in both values. Indomethacin may provide a useful means of reducing proteinuria and controlling edema in some patients with the nephrotic syndrome.

Original languageEnglish (US)
Pages (from-to)1264-1266
Number of pages3
JournalJAMA: The Journal of the American Medical Association
Volume241
Issue number12
DOIs
StatePublished - Mar 23 1979

Fingerprint

Nephrotic Syndrome
Prostaglandins E
Indomethacin
Prostaglandins F
Proteinuria
Edema
Membranous Glomerulonephritis
Therapeutics
Diuretics
Proteins
Salts

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Shehadeh, I. H., Schoolwerth, A. C., Abt, A. B., & Demers, L. (1979). Indomethacin and the Nephrotic Syndrome. JAMA: The Journal of the American Medical Association, 241(12), 1264-1266. https://doi.org/10.1001/jama.1979.03290380040025
Shehadeh, Isam H. ; Schoolwerth, Anton C. ; Abt, Arthur B. ; Demers, Laurence. / Indomethacin and the Nephrotic Syndrome. In: JAMA: The Journal of the American Medical Association. 1979 ; Vol. 241, No. 12. pp. 1264-1266.
@article{86799a63b84149679c760507d265f91d,
title = "Indomethacin and the Nephrotic Syndrome",
abstract = "Treatment of membranous nephropathy and the nephrotic syndrome with 2 mg/kg/day of indomethacin resulted in prompt and sustained reduction in urinary protein excretion and the loss of edema fluid, which allowed the withdrawal of diuretic therapy and liberalization of salt intake. The reduction in proteinuria was paralleled by a decrease in urinary prostaglandin E (PGE) and F (PGF) levels. Plasma PGE and PGF levels did not change appreciably. Withdrawal of indomethacin therapy resulted in an increase in urinary protein and urinary PGE excretion. Reinstitution of therapy resulted in reductions in both values. Indomethacin may provide a useful means of reducing proteinuria and controlling edema in some patients with the nephrotic syndrome.",
author = "Shehadeh, {Isam H.} and Schoolwerth, {Anton C.} and Abt, {Arthur B.} and Laurence Demers",
year = "1979",
month = "3",
day = "23",
doi = "10.1001/jama.1979.03290380040025",
language = "English (US)",
volume = "241",
pages = "1264--1266",
journal = "JAMA - Journal of the American Medical Association",
issn = "0002-9955",
publisher = "American Medical Association",
number = "12",

}

Shehadeh, IH, Schoolwerth, AC, Abt, AB & Demers, L 1979, 'Indomethacin and the Nephrotic Syndrome', JAMA: The Journal of the American Medical Association, vol. 241, no. 12, pp. 1264-1266. https://doi.org/10.1001/jama.1979.03290380040025

Indomethacin and the Nephrotic Syndrome. / Shehadeh, Isam H.; Schoolwerth, Anton C.; Abt, Arthur B.; Demers, Laurence.

In: JAMA: The Journal of the American Medical Association, Vol. 241, No. 12, 23.03.1979, p. 1264-1266.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Indomethacin and the Nephrotic Syndrome

AU - Shehadeh, Isam H.

AU - Schoolwerth, Anton C.

AU - Abt, Arthur B.

AU - Demers, Laurence

PY - 1979/3/23

Y1 - 1979/3/23

N2 - Treatment of membranous nephropathy and the nephrotic syndrome with 2 mg/kg/day of indomethacin resulted in prompt and sustained reduction in urinary protein excretion and the loss of edema fluid, which allowed the withdrawal of diuretic therapy and liberalization of salt intake. The reduction in proteinuria was paralleled by a decrease in urinary prostaglandin E (PGE) and F (PGF) levels. Plasma PGE and PGF levels did not change appreciably. Withdrawal of indomethacin therapy resulted in an increase in urinary protein and urinary PGE excretion. Reinstitution of therapy resulted in reductions in both values. Indomethacin may provide a useful means of reducing proteinuria and controlling edema in some patients with the nephrotic syndrome.

AB - Treatment of membranous nephropathy and the nephrotic syndrome with 2 mg/kg/day of indomethacin resulted in prompt and sustained reduction in urinary protein excretion and the loss of edema fluid, which allowed the withdrawal of diuretic therapy and liberalization of salt intake. The reduction in proteinuria was paralleled by a decrease in urinary prostaglandin E (PGE) and F (PGF) levels. Plasma PGE and PGF levels did not change appreciably. Withdrawal of indomethacin therapy resulted in an increase in urinary protein and urinary PGE excretion. Reinstitution of therapy resulted in reductions in both values. Indomethacin may provide a useful means of reducing proteinuria and controlling edema in some patients with the nephrotic syndrome.

UR - http://www.scopus.com/inward/record.url?scp=0018758549&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018758549&partnerID=8YFLogxK

U2 - 10.1001/jama.1979.03290380040025

DO - 10.1001/jama.1979.03290380040025

M3 - Article

VL - 241

SP - 1264

EP - 1266

JO - JAMA - Journal of the American Medical Association

JF - JAMA - Journal of the American Medical Association

SN - 0002-9955

IS - 12

ER -